Furthermore, NSC348884, an NPM1 inhibitor that disrupts oligomer formation and induces apoptosis, has demonstrated antitumor activity in CRC and Ewing sarcoma cells in vitro [45,128]. Here, NPM1 is linked to colorectal carcinoma.